Skip to content

Fighting to Preserve the Benefits of the 340B Program

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles
  • IRA Resource Center
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles
  • IRA Resource Center

RWC-340B Letter to Novo Nordisk CEO Objecting to Policy Requiring Covered Entities to Submit Claims-level Data

RWC-340BBy RWC-340BMarch 30, 2026

03/30/2026 – RWC-340B Letter to Novo Nordisk CEO Objecting to Policy Requiring Covered Entities to Submit Claims-Level Data RWC-340B sent a letter to Novo Nordisk’s CEO on March 26, 2026,…

RWC-340B Objects to Eli Lilly’s Claims Submission Mandate as Unprecedented, Violation of Federal Law

RWC-340BBy RWC-340BMarch 9, 2026

03/09/2026 – RWC-340B Objects to Eli Lilly’s Claims Submission Mandate as Unprecedented, Violation of Federal Law RWC-340B sent a letter to Eli Lilly’s CEO on February 18, 2026, objecting to…

Novo Nordisk Announces Covered Entities Must Submit Claims Data for All of Its Products

RWC-340BBy RWC-340BMarch 6, 2026

3/6/2026 – Novo Nordisk Announces Covered Entities Must Submit Claims Data for All of Its Products Pharmaceutical manufacturer Novo Nordisk (Novo) announced in a notice that, effective April 1, all covered…

                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »